| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 33 | 2024 | 2747 | 2.220 |
Why?
|
| Influenza A virus | 6 | 2020 | 455 | 1.880 |
Why?
|
| Antigens, Neoplasm | 20 | 2022 | 1998 | 1.740 |
Why?
|
| Host-Pathogen Interactions | 12 | 2022 | 1466 | 1.610 |
Why?
|
| Single-Cell Analysis | 25 | 2024 | 2534 | 1.420 |
Why?
|
| Immunotherapy | 16 | 2024 | 4747 | 1.200 |
Why?
|
| Immunity | 5 | 2023 | 1002 | 1.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 18 | 2024 | 4652 | 1.150 |
Why?
|
| Melanoma | 17 | 2024 | 5700 | 1.140 |
Why?
|
| Antigen Presentation | 12 | 2021 | 1250 | 1.140 |
Why?
|
| Golgi Apparatus | 2 | 2024 | 405 | 1.030 |
Why?
|
| Sequence Analysis, RNA | 19 | 2023 | 2039 | 1.000 |
Why?
|
| Autoimmune Diseases | 7 | 2022 | 2254 | 1.000 |
Why?
|
| Macrophages | 14 | 2023 | 5783 | 0.990 |
Why?
|
| Immune System | 4 | 2019 | 800 | 0.980 |
Why?
|
| Membrane Proteins | 10 | 2024 | 7868 | 0.960 |
Why?
|
| T-Lymphocytes | 19 | 2022 | 10264 | 0.910 |
Why?
|
| Interferon Regulatory Factor-3 | 3 | 2023 | 145 | 0.840 |
Why?
|
| Neoplasms | 29 | 2024 | 22350 | 0.820 |
Why?
|
| Monocytes | 9 | 2021 | 2600 | 0.790 |
Why?
|
| Nucleotides, Cyclic | 1 | 2023 | 83 | 0.790 |
Why?
|
| Protein Transport | 5 | 2024 | 1942 | 0.790 |
Why?
|
| Cell Nucleus | 4 | 2019 | 2870 | 0.770 |
Why?
|
| Receptors, IgG | 2 | 2022 | 562 | 0.770 |
Why?
|
| Influenza, Human | 4 | 2022 | 1543 | 0.760 |
Why?
|
| Legionella pneumophila | 1 | 2021 | 50 | 0.760 |
Why?
|
| Immunity, Innate | 15 | 2023 | 3077 | 0.750 |
Why?
|
| Gene Expression Profiling | 26 | 2024 | 9525 | 0.750 |
Why?
|
| Cancer Vaccines | 11 | 2021 | 1042 | 0.750 |
Why?
|
| Epitopes | 9 | 2021 | 2526 | 0.730 |
Why?
|
| Histocompatibility Antigens Class I | 10 | 2023 | 1362 | 0.720 |
Why?
|
| Lupus Nephritis | 5 | 2024 | 324 | 0.710 |
Why?
|
| Gene Expression Regulation | 21 | 2023 | 11920 | 0.710 |
Why?
|
| Sepsis | 4 | 2024 | 2604 | 0.700 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2022 | 1363 | 0.690 |
Why?
|
| Signal Transduction | 27 | 2024 | 23619 | 0.690 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 301 | 0.680 |
Why?
|
| Trypanosoma cruzi | 1 | 2021 | 204 | 0.660 |
Why?
|
| RNA, Small Interfering | 17 | 2017 | 3425 | 0.660 |
Why?
|
| Alternative Splicing | 4 | 2021 | 1103 | 0.660 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2023 | 3666 | 0.650 |
Why?
|
| Microscopy | 1 | 2024 | 902 | 0.650 |
Why?
|
| Toll-Like Receptors | 7 | 2018 | 582 | 0.640 |
Why?
|
| Ion Channels | 2 | 2023 | 1043 | 0.610 |
Why?
|
| Aminopeptidases | 1 | 2018 | 114 | 0.590 |
Why?
|
| Systems Biology | 2 | 2013 | 481 | 0.590 |
Why?
|
| Protons | 1 | 2023 | 1097 | 0.590 |
Why?
|
| Endodeoxyribonucleases | 2 | 2019 | 165 | 0.580 |
Why?
|
| Computational Biology | 9 | 2022 | 3564 | 0.560 |
Why?
|
| DNA Damage | 2 | 2019 | 2467 | 0.560 |
Why?
|
| Proteomics | 11 | 2024 | 3914 | 0.560 |
Why?
|
| Interferon-gamma | 4 | 2023 | 3158 | 0.560 |
Why?
|
| Cytokines | 11 | 2024 | 7438 | 0.530 |
Why?
|
| Animals | 93 | 2024 | 168930 | 0.530 |
Why?
|
| Flow Cytometry | 13 | 2019 | 5890 | 0.520 |
Why?
|
| Tumor Microenvironment | 12 | 2024 | 3944 | 0.520 |
Why?
|
| DNA | 5 | 2019 | 7208 | 0.500 |
Why?
|
| Virus Replication | 4 | 2020 | 2457 | 0.500 |
Why?
|
| Humans | 175 | 2024 | 766766 | 0.500 |
Why?
|
| Genomics | 10 | 2023 | 5923 | 0.480 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2014 | 36 | 0.480 |
Why?
|
| Chemokines | 4 | 2024 | 962 | 0.480 |
Why?
|
| STAT Transcription Factors | 2 | 2023 | 189 | 0.470 |
Why?
|
| Peptides | 10 | 2023 | 4344 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 30 | 2024 | 22352 | 0.460 |
Why?
|
| Mice | 67 | 2024 | 81889 | 0.450 |
Why?
|
| Bone Marrow Cells | 7 | 2020 | 2413 | 0.450 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 12806 | 0.450 |
Why?
|
| Quantitative Trait Loci | 7 | 2018 | 2136 | 0.440 |
Why?
|
| Genetic Loci | 3 | 2020 | 2630 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2022 | 18075 | 0.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2024 | 4410 | 0.420 |
Why?
|
| HEK293 Cells | 11 | 2023 | 4276 | 0.420 |
Why?
|
| RNA | 9 | 2023 | 2715 | 0.410 |
Why?
|
| Cell Cycle Proteins | 4 | 2020 | 3439 | 0.400 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 6962 | 0.390 |
Why?
|
| Interferon Type I | 5 | 2020 | 568 | 0.390 |
Why?
|
| Immunogenetics | 1 | 2011 | 62 | 0.390 |
Why?
|
| Atlases as Topic | 3 | 2024 | 247 | 0.390 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1425 | 0.380 |
Why?
|
| Viruses | 3 | 2013 | 371 | 0.380 |
Why?
|
| Allergy and Immunology | 1 | 2013 | 170 | 0.370 |
Why?
|
| Immunologic Memory | 7 | 2024 | 1377 | 0.370 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 6 | 2024 | 1105 | 0.370 |
Why?
|
| Bacteria | 2 | 2020 | 2212 | 0.350 |
Why?
|
| Lymphocyte Activation | 12 | 2024 | 5503 | 0.350 |
Why?
|
| Mammals | 3 | 2023 | 1133 | 0.350 |
Why?
|
| Transcription, Genetic | 12 | 2021 | 7609 | 0.340 |
Why?
|
| Interferons | 6 | 2020 | 714 | 0.340 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 313 | 0.340 |
Why?
|
| B-Lymphocytes | 9 | 2023 | 4784 | 0.340 |
Why?
|
| DNA-Binding Proteins | 4 | 2024 | 9611 | 0.330 |
Why?
|
| Cells, Cultured | 20 | 2021 | 18984 | 0.330 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5329 | 0.330 |
Why?
|
| Myeloid Cells | 4 | 2023 | 838 | 0.330 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 566 | 0.330 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 3 | 2017 | 69 | 0.330 |
Why?
|
| Immune Evasion | 3 | 2023 | 375 | 0.320 |
Why?
|
| Mice, Knockout | 18 | 2024 | 14471 | 0.320 |
Why?
|
| Hepatitis B, Chronic | 2 | 2024 | 413 | 0.320 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 592 | 0.320 |
Why?
|
| Fibroblasts | 5 | 2021 | 4166 | 0.320 |
Why?
|
| Melanoma, Experimental | 4 | 2021 | 557 | 0.320 |
Why?
|
| Genome | 2 | 2016 | 1752 | 0.320 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 5795 | 0.320 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2018 | 1642 | 0.310 |
Why?
|
| Viral Proteins | 2 | 2020 | 1801 | 0.310 |
Why?
|
| Lipopolysaccharides | 10 | 2021 | 2214 | 0.300 |
Why?
|
| Genetic Variation | 8 | 2021 | 6612 | 0.300 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 17088 | 0.300 |
Why?
|
| Antigens | 3 | 2023 | 1441 | 0.300 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2023 | 827 | 0.290 |
Why?
|
| Proteome | 6 | 2021 | 1894 | 0.290 |
Why?
|
| Cell Line | 16 | 2021 | 15563 | 0.290 |
Why?
|
| Cell Communication | 4 | 2023 | 1660 | 0.290 |
Why?
|
| Epigenesis, Genetic | 7 | 2024 | 3824 | 0.290 |
Why?
|
| Antiviral Agents | 6 | 2023 | 3070 | 0.280 |
Why?
|
| Gene Regulatory Networks | 7 | 2021 | 1751 | 0.280 |
Why?
|
| Interleukin-1beta | 4 | 2023 | 1026 | 0.280 |
Why?
|
| Lymph Nodes | 4 | 2023 | 3468 | 0.280 |
Why?
|
| Synovial Membrane | 3 | 2019 | 536 | 0.280 |
Why?
|
| Lentivirus | 6 | 2014 | 518 | 0.280 |
Why?
|
| Interferon-beta | 3 | 2020 | 348 | 0.280 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2198 | 0.270 |
Why?
|
| RNA Splicing | 4 | 2018 | 903 | 0.270 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2022 | 255 | 0.270 |
Why?
|
| Th17 Cells | 4 | 2020 | 790 | 0.270 |
Why?
|
| Virus Diseases | 1 | 2013 | 720 | 0.270 |
Why?
|
| Inflammation | 7 | 2024 | 10860 | 0.270 |
Why?
|
| Software | 6 | 2023 | 4466 | 0.270 |
Why?
|
| Insect Proteins | 5 | 1999 | 253 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2021 | 2902 | 0.270 |
Why?
|
| Kidney | 6 | 2022 | 7074 | 0.260 |
Why?
|
| RNA-Binding Proteins | 5 | 2017 | 1884 | 0.260 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2009 | 496 | 0.260 |
Why?
|
| DNA, Viral | 1 | 2012 | 2201 | 0.250 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 453 | 0.250 |
Why?
|
| Oligosaccharides | 1 | 2008 | 406 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2020 | 3186 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2021 | 2571 | 0.250 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2017 | 658 | 0.250 |
Why?
|
| Killer Cells, Natural | 3 | 2024 | 2210 | 0.250 |
Why?
|
| Genetic Techniques | 2 | 2020 | 428 | 0.240 |
Why?
|
| Mice, Transgenic | 11 | 2021 | 9547 | 0.240 |
Why?
|
| Endopeptidases | 2 | 2023 | 762 | 0.240 |
Why?
|
| Autoimmunity | 5 | 2019 | 1358 | 0.230 |
Why?
|
| Methyltransferases | 2 | 2020 | 373 | 0.230 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 872 | 0.230 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1182 | 0.230 |
Why?
|
| RNA Interference | 9 | 2016 | 2827 | 0.230 |
Why?
|
| T-Cell Antigen Receptor Specificity | 2 | 2018 | 89 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 2 | 2023 | 1033 | 0.220 |
Why?
|
| Disease Susceptibility | 3 | 2020 | 1791 | 0.220 |
Why?
|
| Immunogenetic Phenomena | 2 | 2015 | 23 | 0.220 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13485 | 0.220 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2024 | 176 | 0.220 |
Why?
|
| Mutation | 17 | 2023 | 30213 | 0.220 |
Why?
|
| Hepatitis B virus | 2 | 2024 | 531 | 0.220 |
Why?
|
| Candida albicans | 2 | 2009 | 377 | 0.220 |
Why?
|
| Receptors, Cell Surface | 4 | 2020 | 2815 | 0.210 |
Why?
|
| Chemokine CXCL9 | 1 | 2023 | 137 | 0.210 |
Why?
|
| Gene Library | 5 | 2011 | 1065 | 0.210 |
Why?
|
| Gene Knockout Techniques | 3 | 2024 | 803 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5753 | 0.210 |
Why?
|
| Receptors, Immunologic | 3 | 2020 | 1418 | 0.210 |
Why?
|
| Poly I-C | 2 | 2021 | 110 | 0.210 |
Why?
|
| Leukemia, Myeloid | 2 | 2017 | 695 | 0.210 |
Why?
|
| Complementarity Determining Regions | 3 | 2019 | 154 | 0.200 |
Why?
|
| Cross Reactions | 2 | 2021 | 826 | 0.200 |
Why?
|
| Models, Genetic | 2 | 2020 | 3450 | 0.200 |
Why?
|
| Interleukin-16 | 1 | 2022 | 34 | 0.200 |
Why?
|
| Ligands | 4 | 2023 | 3275 | 0.200 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1351 | 0.200 |
Why?
|
| Genome, Human | 6 | 2021 | 4443 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 665 | 0.200 |
Why?
|
| DNA, Complementary | 2 | 2023 | 1989 | 0.200 |
Why?
|
| Interleukin-18 | 1 | 2023 | 251 | 0.200 |
Why?
|
| Protein Isoforms | 4 | 2023 | 1716 | 0.200 |
Why?
|
| RNA Viruses | 1 | 2023 | 110 | 0.190 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2023 | 146 | 0.190 |
Why?
|
| Leukocytes | 5 | 2023 | 2035 | 0.190 |
Why?
|
| Endosomes | 2 | 2018 | 521 | 0.190 |
Why?
|
| Viremia | 2 | 2022 | 727 | 0.190 |
Why?
|
| Osteopontin | 1 | 2023 | 305 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9244 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2020 | 2160 | 0.190 |
Why?
|
| Vero Cells | 2 | 2020 | 486 | 0.180 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2021 | 98 | 0.180 |
Why?
|
| Neutrophils | 3 | 2023 | 3782 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2021 | 588 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 2 | 2024 | 1132 | 0.180 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 383 | 0.180 |
Why?
|
| Plasma Cells | 1 | 2024 | 599 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
| Dibenzothiepins | 1 | 2020 | 8 | 0.170 |
Why?
|
| Thiepins | 1 | 2020 | 5 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1089 | 0.170 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2020 | 55 | 0.170 |
Why?
|
| Phosphotransferases | 2 | 2012 | 302 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 513 | 0.170 |
Why?
|
| Apoptosis | 6 | 2020 | 9513 | 0.170 |
Why?
|
| Open Reading Frames | 2 | 2021 | 818 | 0.170 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 455 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2023 | 637 | 0.170 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3702 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2023 | 2478 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 938 | 0.170 |
Why?
|
| Organ Specificity | 3 | 2021 | 1966 | 0.170 |
Why?
|
| Uniparental Disomy | 1 | 2019 | 46 | 0.170 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3581 | 0.170 |
Why?
|
| Epitope Mapping | 1 | 2020 | 301 | 0.160 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 2 | 2019 | 526 | 0.160 |
Why?
|
| Liposomes | 1 | 2023 | 787 | 0.160 |
Why?
|
| Virus Internalization | 2 | 2021 | 504 | 0.160 |
Why?
|
| Female | 45 | 2024 | 396520 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8621 | 0.160 |
Why?
|
| Cryosurgery | 1 | 2024 | 478 | 0.160 |
Why?
|
| Endothelium | 1 | 2022 | 768 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2012 | 415 | 0.160 |
Why?
|
| Chaperonins | 2 | 2012 | 58 | 0.160 |
Why?
|
| P-Selectin | 1 | 2021 | 598 | 0.160 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 123 | 0.160 |
Why?
|
| Mitochondria | 4 | 2021 | 3677 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Models, Immunological | 2 | 2011 | 517 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2023 | 1802 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 3788 | 0.160 |
Why?
|
| Liver | 3 | 2024 | 7571 | 0.150 |
Why?
|
| Antigens, CD | 2 | 2020 | 4032 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 281 | 0.150 |
Why?
|
| Immunization | 1 | 2023 | 1218 | 0.150 |
Why?
|
| Crohn Disease | 3 | 2020 | 2286 | 0.150 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.150 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 432 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 3 | 1999 | 871 | 0.150 |
Why?
|
| Conserved Sequence | 3 | 2015 | 1159 | 0.150 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 196 | 0.150 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2020 | 329 | 0.150 |
Why?
|
| Pyridones | 2 | 2023 | 818 | 0.150 |
Why?
|
| Jurkat Cells | 5 | 2021 | 740 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2023 | 541 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 1071 | 0.150 |
Why?
|
| HLA Antigens | 5 | 2023 | 1339 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 3041 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 36 | 0.150 |
Why?
|
| Triazines | 1 | 2020 | 311 | 0.150 |
Why?
|
| Immunological Synapses | 1 | 2018 | 58 | 0.150 |
Why?
|
| Protein Engineering | 1 | 2021 | 554 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 2929 | 0.140 |
Why?
|
| Hepacivirus | 2 | 2023 | 1343 | 0.140 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 134 | 0.140 |
Why?
|
| Databases, Protein | 1 | 2019 | 390 | 0.140 |
Why?
|
| Transcription Factors | 8 | 2018 | 12150 | 0.140 |
Why?
|
| Oxazines | 1 | 2020 | 358 | 0.140 |
Why?
|
| Phagocytes | 2 | 2021 | 292 | 0.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2013 | 685 | 0.140 |
Why?
|
| Epithelial Cells | 7 | 2024 | 3691 | 0.140 |
Why?
|
| beta Catenin | 2 | 2014 | 1048 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 2015 | 1325 | 0.140 |
Why?
|
| Lysosomes | 2 | 2014 | 937 | 0.140 |
Why?
|
| Chromosomes | 1 | 2020 | 578 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1750 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 608 | 0.140 |
Why?
|
| Hematopoiesis | 4 | 2020 | 2060 | 0.140 |
Why?
|
| Chromatin | 4 | 2020 | 2977 | 0.140 |
Why?
|
| Escherichia coli | 3 | 2014 | 4211 | 0.140 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 99 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 308 | 0.140 |
Why?
|
| Drosophila Proteins | 4 | 1999 | 1704 | 0.140 |
Why?
|
| DNA Methylation | 4 | 2020 | 4427 | 0.140 |
Why?
|
| Drosophila | 4 | 1999 | 1508 | 0.140 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3212 | 0.140 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1384 | 0.140 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.140 |
Why?
|
| Classification | 1 | 2017 | 128 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 498 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2021 | 557 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 330 | 0.140 |
Why?
|
| Cell Differentiation | 9 | 2024 | 11651 | 0.140 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2020 | 336 | 0.130 |
Why?
|
| Morpholines | 1 | 2020 | 584 | 0.130 |
Why?
|
| Eukaryotic Cells | 1 | 2017 | 192 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 838 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 423 | 0.130 |
Why?
|
| Base Sequence | 9 | 2023 | 12415 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 844 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 792 | 0.130 |
Why?
|
| Oncogenes | 2 | 2014 | 1231 | 0.130 |
Why?
|
| Alleles | 7 | 2022 | 6895 | 0.130 |
Why?
|
| Cell Lineage | 5 | 2019 | 2572 | 0.130 |
Why?
|
| Apyrase | 1 | 2018 | 376 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 2010 | 0.130 |
Why?
|
| Gene Silencing | 5 | 2014 | 1504 | 0.130 |
Why?
|
| Vesiculovirus | 2 | 2012 | 52 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2021 | 1334 | 0.130 |
Why?
|
| Metals, Heavy | 1 | 2017 | 149 | 0.130 |
Why?
|
| Virus Release | 1 | 2015 | 35 | 0.130 |
Why?
|
| Epigenomics | 2 | 2020 | 959 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2018 | 1756 | 0.120 |
Why?
|
| Colitis | 1 | 2024 | 1238 | 0.120 |
Why?
|
| Lymphocyte Transfusion | 2 | 2013 | 236 | 0.120 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 229 | 0.120 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 663 | 0.120 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 880 | 0.120 |
Why?
|
| Lung | 3 | 2021 | 10067 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 221 | 0.120 |
Why?
|
| Colon | 2 | 2024 | 1797 | 0.120 |
Why?
|
| Models, Animal | 1 | 2021 | 2121 | 0.120 |
Why?
|
| Genetic Engineering | 2 | 2014 | 936 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2014 | 393 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2021 | 1003 | 0.120 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 1996 | 0.120 |
Why?
|
| Receptors, Scavenger | 2 | 2020 | 123 | 0.120 |
Why?
|
| Neoplasms, Experimental | 2 | 2017 | 1227 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 1150 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 1197 | 0.120 |
Why?
|
| Genomic Imprinting | 2 | 2019 | 326 | 0.120 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 193 | 0.120 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2015 | 238 | 0.120 |
Why?
|
| Neoplasm Metastasis | 3 | 2024 | 4891 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1964 | 0.120 |
Why?
|
| Schistosoma | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2021 | 41710 | 0.120 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 381 | 0.120 |
Why?
|
| Poxviridae Infections | 1 | 2014 | 10 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 20144 | 0.110 |
Why?
|
| Orthopoxvirus | 1 | 2014 | 10 | 0.110 |
Why?
|
| Lymphocytes | 2 | 2019 | 2605 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6222 | 0.110 |
Why?
|
| Gene Expression | 4 | 2020 | 7585 | 0.110 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 148 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 949 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 169 | 0.110 |
Why?
|
| Schistosomiasis | 1 | 2014 | 65 | 0.110 |
Why?
|
| Endogenous Retroviruses | 1 | 2015 | 111 | 0.110 |
Why?
|
| Microfluidics | 1 | 2019 | 650 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2019 | 1442 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2018 | 960 | 0.110 |
Why?
|
| Haplotypes | 1 | 2020 | 2727 | 0.110 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2013 | 16 | 0.110 |
Why?
|
| Binding Sites | 1 | 2022 | 6012 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2018 | 1075 | 0.110 |
Why?
|
| Phenotype | 10 | 2022 | 16724 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 760 | 0.110 |
Why?
|
| Body Patterning | 1 | 1998 | 634 | 0.110 |
Why?
|
| Cell Separation | 1 | 2019 | 1718 | 0.110 |
Why?
|
| HMGB2 Protein | 1 | 2012 | 7 | 0.110 |
Why?
|
| Drug Industry | 1 | 2020 | 791 | 0.110 |
Why?
|
| Vaccination | 2 | 2023 | 3434 | 0.110 |
Why?
|
| Male | 29 | 2024 | 364142 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2014 | 168 | 0.110 |
Why?
|
| Nanowires | 1 | 2012 | 31 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 856 | 0.100 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 255 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2023 | 1595 | 0.100 |
Why?
|
| Biological Products | 1 | 2022 | 948 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2014 | 277 | 0.100 |
Why?
|
| Skin Neoplasms | 4 | 2024 | 5861 | 0.100 |
Why?
|
| Cell Division | 3 | 2020 | 4474 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 2184 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2022 | 16044 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 1029 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1271 | 0.100 |
Why?
|
| Ribosomes | 1 | 2015 | 496 | 0.100 |
Why?
|
| Ubiquitinated Proteins | 1 | 2012 | 32 | 0.100 |
Why?
|
| Point Mutation | 1 | 2017 | 1591 | 0.100 |
Why?
|
| Vesicular Stomatitis | 1 | 2012 | 18 | 0.100 |
Why?
|
| Silicon | 1 | 2012 | 141 | 0.100 |
Why?
|
| Adult | 19 | 2024 | 223307 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2020 | 4780 | 0.100 |
Why?
|
| Models, Biological | 3 | 2021 | 9461 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2015 | 12791 | 0.100 |
Why?
|
| ROC Curve | 1 | 2020 | 3620 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 231 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2019 | 1814 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2011 | 347 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3408 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 606 | 0.100 |
Why?
|
| Host-Parasite Interactions | 1 | 2014 | 303 | 0.100 |
Why?
|
| Metals, Rare Earth | 1 | 2011 | 16 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2011 | 247 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1882 | 0.090 |
Why?
|
| Transforming Growth Factors | 1 | 2011 | 76 | 0.090 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2011 | 48 | 0.090 |
Why?
|
| Immunologic Factors | 3 | 2021 | 1594 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5789 | 0.090 |
Why?
|
| Proteolipids | 1 | 2011 | 109 | 0.090 |
Why?
|
| Spliceosomes | 1 | 2011 | 116 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2015 | 582 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 6359 | 0.090 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2011 | 131 | 0.090 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2011 | 122 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2018 | 3591 | 0.090 |
Why?
|
| Autophagy | 2 | 2018 | 1346 | 0.090 |
Why?
|
| Algorithms | 6 | 2020 | 14072 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5387 | 0.090 |
Why?
|
| Feedback, Physiological | 2 | 2009 | 481 | 0.090 |
Why?
|
| Necrosis | 1 | 2015 | 1616 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1757 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 4619 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2024 | 1852 | 0.090 |
Why?
|
| Synaptotagmins | 1 | 2010 | 53 | 0.090 |
Why?
|
| Young Adult | 7 | 2021 | 59939 | 0.090 |
Why?
|
| Kinetics | 4 | 2022 | 6287 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1057 | 0.090 |
Why?
|
| Hair Cells, Auditory | 2 | 1989 | 382 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.080 |
Why?
|
| ras Proteins | 2 | 2014 | 1055 | 0.080 |
Why?
|
| Peroxisomes | 1 | 2010 | 63 | 0.080 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 200 | 0.080 |
Why?
|
| Saccule and Utricle | 1 | 1989 | 81 | 0.080 |
Why?
|
| Cytosol | 1 | 2012 | 887 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1885 | 0.080 |
Why?
|
| Genetic Vectors | 3 | 2014 | 3401 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2783 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 512 | 0.080 |
Why?
|
| Protein Binding | 6 | 2021 | 9320 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2015 | 2045 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 463 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 1243 | 0.080 |
Why?
|
| Viral Load | 3 | 2024 | 3385 | 0.080 |
Why?
|
| Janus Kinases | 2 | 2023 | 253 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1946 | 0.080 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2009 | 163 | 0.080 |
Why?
|
| Cryptococcus neoformans | 1 | 2009 | 110 | 0.080 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2009 | 228 | 0.070 |
Why?
|
| Myocardium | 1 | 2021 | 4765 | 0.070 |
Why?
|
| Benzamides | 1 | 2014 | 1375 | 0.070 |
Why?
|
| Middle Aged | 14 | 2024 | 223257 | 0.070 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 319 | 0.070 |
Why?
|
| Phagosomes | 1 | 2009 | 194 | 0.070 |
Why?
|
| Pyridines | 1 | 2020 | 2888 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 4400 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 1920 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1612 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1604 | 0.070 |
Why?
|
| Cell Survival | 5 | 2017 | 5748 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2093 | 0.070 |
Why?
|
| Genotype | 1 | 2022 | 13036 | 0.070 |
Why?
|
| Disease Progression | 5 | 2024 | 13640 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2021 | 2867 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 13411 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2014 | 2470 | 0.070 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 734 | 0.070 |
Why?
|
| Renin-Angiotensin System | 2 | 2022 | 737 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2012 | 1007 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 740 | 0.070 |
Why?
|
| Bacterial Proteins | 3 | 2018 | 3833 | 0.070 |
Why?
|
| Microarray Analysis | 3 | 2019 | 751 | 0.070 |
Why?
|
| Autopsy | 2 | 2021 | 1011 | 0.070 |
Why?
|
| MafB Transcription Factor | 2 | 2017 | 25 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2306 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 800 | 0.070 |
Why?
|
| cdc25 Phosphatases | 1 | 2006 | 60 | 0.070 |
Why?
|
| Clone Cells | 2 | 2020 | 1670 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2429 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2014 | 3796 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1741 | 0.070 |
Why?
|
| HIV-1 | 3 | 2016 | 6948 | 0.070 |
Why?
|
| Ovalbumin | 1 | 2008 | 677 | 0.060 |
Why?
|
| Internet | 1 | 2018 | 3113 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15908 | 0.060 |
Why?
|
| Calcium Channels | 1 | 1989 | 622 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4215 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2009 | 722 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4591 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2014 | 872 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 996 | 0.060 |
Why?
|
| Cell Proliferation | 6 | 2024 | 10445 | 0.060 |
Why?
|
| Aging | 1 | 2024 | 8731 | 0.060 |
Why?
|
| Exosomes | 1 | 2009 | 417 | 0.060 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 17608 | 0.060 |
Why?
|
| NF-kappa B | 4 | 2011 | 2493 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 1148 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2717 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13643 | 0.060 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2024 | 140 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3601 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2014 | 1647 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14652 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 2006 | 358 | 0.060 |
Why?
|
| Cell Movement | 3 | 2010 | 5199 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 3636 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5444 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2448 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 1504 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2018 | 3458 | 0.050 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8717 | 0.050 |
Why?
|
| HeLa Cells | 4 | 2011 | 3073 | 0.050 |
Why?
|
| Respiratory System | 2 | 1996 | 562 | 0.050 |
Why?
|
| Aged | 11 | 2024 | 171343 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2730 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 38 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2936 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 479 | 0.050 |
Why?
|
| RNA Stability | 2 | 2014 | 319 | 0.050 |
Why?
|
| Antibodies | 2 | 2021 | 2421 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 874 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2823 | 0.050 |
Why?
|
| Histones | 1 | 2013 | 2593 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2013 | 1527 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2009 | 1892 | 0.050 |
Why?
|
| Isotope Labeling | 2 | 2015 | 390 | 0.050 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 20 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2009 | 1367 | 0.050 |
Why?
|
| Angiotensins | 1 | 2022 | 140 | 0.050 |
Why?
|
| Chemical Fractionation | 1 | 2021 | 60 | 0.050 |
Why?
|
| Mannans | 1 | 2001 | 58 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 3043 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 47 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4570 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 4349 | 0.050 |
Why?
|
| Trachea | 2 | 1998 | 1094 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6259 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2020 | 2510 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2023 | 328 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 1999 | 3609 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3692 | 0.040 |
Why?
|
| Proteinuria | 1 | 2024 | 613 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3607 | 0.040 |
Why?
|
| Cross-Priming | 2 | 2012 | 75 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2006 | 2926 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2021 | 275 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 445 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2023 | 385 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2001 | 292 | 0.040 |
Why?
|
| Germinal Center | 1 | 2023 | 379 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 635 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1319 | 0.040 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2020 | 50 | 0.040 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
| Renin | 1 | 2022 | 647 | 0.040 |
Why?
|
| Up-Regulation | 4 | 2011 | 4142 | 0.040 |
Why?
|
| Caspase 1 | 2 | 2011 | 227 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 881 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 1474 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 59550 | 0.040 |
Why?
|
| Calcium | 2 | 1989 | 5783 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 401 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 2801 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 784 | 0.040 |
Why?
|
| Mesentery | 1 | 2020 | 201 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2024 | 853 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2022 | 6104 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
| Aggression | 1 | 2024 | 748 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3587 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 1911 | 0.040 |
Why?
|
| Research Personnel | 1 | 2023 | 589 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4559 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 992 | 0.040 |
Why?
|
| Transposases | 1 | 2019 | 106 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 103 | 0.040 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2023 | 426 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 684 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2022 | 960 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 754 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 792 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1889 | 0.040 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2018 | 73 | 0.040 |
Why?
|
| Causality | 1 | 2024 | 1252 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 747 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 671 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 735 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 1999 | 183 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 260 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 207 | 0.040 |
Why?
|
| Sirtuins | 1 | 2021 | 322 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 537 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 1131 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 2 | 2011 | 376 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2019 | 419 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 371 | 0.040 |
Why?
|
| Aminoacyltransferases | 1 | 2018 | 52 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 569 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 508 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1998 | 848 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
| Leprosy | 1 | 2017 | 125 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 203 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 928 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2017 | 32 | 0.030 |
Why?
|
| Drosophila melanogaster | 2 | 1996 | 1725 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2017 | 129 | 0.030 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2016 | 21 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 342 | 0.030 |
Why?
|
| Blood Cells | 1 | 2019 | 308 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 610 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 1892 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2010 | 4924 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1160 | 0.030 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2017 | 112 | 0.030 |
Why?
|
| Prognosis | 3 | 2023 | 29948 | 0.030 |
Why?
|
| Organoids | 1 | 2023 | 740 | 0.030 |
Why?
|
| Adolescent | 3 | 2021 | 88904 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2018 | 4168 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2016 | 2931 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 645 | 0.030 |
Why?
|
| Cell Death | 1 | 2021 | 1676 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2017 | 8307 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2019 | 647 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2016 | 150 | 0.030 |
Why?
|
| Pregnancy | 4 | 2024 | 30237 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 193 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 272 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2016 | 69 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2018 | 528 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2020 | 1392 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 899 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 335 | 0.030 |
Why?
|
| Ascites | 1 | 2017 | 336 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2017 | 319 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.030 |
Why?
|
| Hexosyltransferases | 1 | 2015 | 58 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 787 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3738 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2018 | 542 | 0.030 |
Why?
|
| Adipocytes | 1 | 2002 | 1196 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18330 | 0.030 |
Why?
|
| Tristetraprolin | 1 | 2014 | 40 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 159 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 3641 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2021 | 1895 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2021 | 1497 | 0.030 |
Why?
|
| Sulfites | 1 | 2014 | 83 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 447 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2016 | 491 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3616 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1749 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1370 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1867 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2011 | 1352 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 859 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 147 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 340 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2014 | 205 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2013 | 27 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 351 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5022 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2590 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 439 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 210 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 214 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 93 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 902 | 0.030 |
Why?
|
| Rana catesbeiana | 2 | 1989 | 85 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2018 | 727 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 419 | 0.030 |
Why?
|
| RGS Proteins | 1 | 2013 | 76 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2056 | 0.030 |
Why?
|
| Antioxidants | 1 | 2021 | 1671 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1621 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3947 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 5690 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 474 | 0.030 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2012 | 4 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 146 | 0.030 |
Why?
|
| Iodoacetamide | 1 | 2012 | 33 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2013 | 148 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 11061 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2014 | 202 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 287 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 85 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 8540 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 812 | 0.030 |
Why?
|
| Thiocyanates | 1 | 2012 | 70 | 0.020 |
Why?
|
| Leupeptins | 1 | 2012 | 112 | 0.020 |
Why?
|
| Regeneration | 1 | 2021 | 1520 | 0.020 |
Why?
|
| Semiconductors | 1 | 2013 | 98 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2012 | 68 | 0.020 |
Why?
|
| Granuloma | 1 | 2014 | 329 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2012 | 132 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2012 | 133 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 693 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 182 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2586 | 0.020 |
Why?
|
| Blood Donors | 1 | 2013 | 344 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 794 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1074 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2011 | 84 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
| Multigene Family | 1 | 2014 | 1081 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1434 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 141 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2018 | 1962 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 949 | 0.020 |
Why?
|
| Adenoma | 1 | 2021 | 2155 | 0.020 |
Why?
|
| Survivors | 1 | 2021 | 2379 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 184 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 226 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 412 | 0.020 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 14 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2727 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 3114 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1767 | 0.020 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 51 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 17536 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2354 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 995 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1208 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2015 | 943 | 0.020 |
Why?
|
| Leukemia, T-Cell | 1 | 2010 | 102 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 311 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2024 | 65273 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 828 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1725 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2826 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 73 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2017 | 1142 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 980 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 526 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1989 | 405 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1711 | 0.020 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2010 | 165 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2629 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 750 | 0.020 |
Why?
|
| Morphogenesis | 3 | 1996 | 745 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 108 | 0.020 |
Why?
|
| Nucleic Acids | 1 | 2011 | 189 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 2009 | 99 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2012 | 577 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 457 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 789 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 2295 | 0.020 |
Why?
|
| Heart | 1 | 2021 | 4425 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1900 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2430 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 351 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 269 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1646 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2009 | 3093 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1996 | 2426 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1337 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 826 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1525 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4114 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2010 | 598 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1491 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 549 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2011 | 910 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 54871 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 2978 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2010 | 548 | 0.020 |
Why?
|
| Libraries | 1 | 2006 | 21 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2115 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 372 | 0.020 |
Why?
|
| G2 Phase | 1 | 2006 | 134 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2015 | 6329 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 553 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1989 | 1085 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 729 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 1057 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 630 | 0.010 |
Why?
|
| Epithelium | 1 | 1989 | 1606 | 0.010 |
Why?
|
| Brain | 2 | 2023 | 27159 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 682 | 0.010 |
Why?
|
| Endopeptidase K | 1 | 2004 | 23 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1838 | 0.010 |
Why?
|
| Polymyxin B | 1 | 2004 | 44 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2006 | 957 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4913 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 97 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3227 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 361 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2009 | 2628 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 3035 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2010 | 1246 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2392 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18397 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 915 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4860 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1989 | 1313 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 882 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11872 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2002 | 241 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2746 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8735 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2011 | 2392 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2142 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5386 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6066 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 252 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2391 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1082 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 437 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2884 | 0.010 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1999 | 29 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5143 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3229 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9404 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2885 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5754 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 697 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26310 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1999 | 972 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10100 | 0.010 |
Why?
|
| Nervous System | 1 | 1999 | 542 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 816 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 1996 | 179 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1999 | 628 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2746 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1228 | 0.010 |
Why?
|
| Eye | 1 | 1999 | 710 | 0.010 |
Why?
|
| Species Specificity | 1 | 1999 | 2413 | 0.010 |
Why?
|
| Risk | 1 | 2006 | 9602 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1996 | 577 | 0.010 |
Why?
|
| Extremities | 1 | 1999 | 869 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1677 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 921 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1826 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 1505 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72951 | 0.010 |
Why?
|
| Child | 1 | 2019 | 80668 | 0.010 |
Why?
|
| Time Factors | 2 | 1989 | 40149 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10745 | 0.010 |
Why?
|
| Stem Cells | 1 | 2002 | 3537 | 0.000 |
Why?
|
| Insulin Resistance | 1 | 2002 | 3989 | 0.000 |
Why?
|
| Insulin | 1 | 2002 | 6608 | 0.000 |
Why?
|
| Movement | 1 | 1989 | 1468 | 0.000 |
Why?
|